Soumitra Sahana1*, Sourav Nag1, Prasit Roy1, Reshmi Paul1, Sk Abdur Rahamat1, Indranil Chatterjee2, Suman Kumar Nath3 and Snehansu Biswas3
1B. Pharm, Birbhum Pharmacy School, Birbhum, West Bengal, India
2Assistant Professor, Department of Microbiology, Birbhum Pharmacy School, Birbhum, West Bengal, India
3Assistant Professor, Department of Pharmacognosy, Birbhum Pharmacy School, Birbhum, West Bengal India
*Corresponding Author: Soumitra Sahana, B. Pharm, Birbhum Pharmacy School, Birbhum, West Bengal, India.
Received: August 18, 2020; Published: September 16, 2020
In December 31, 2019, hospitals pronounced a cluster of instances with pneumonia of unknown motive in Wuhan, Hubei, China, attracting brilliant interest nationally and worldwide. The pandemic of coronavirus disease 2019 precipitated by means of the SARS-CoV-2 offers an unheard of venture to discover superb capsules for treatment. Given the speedy tempo of scientific discovery and medical statistics generated by means of the massive quantity of human beings unexpectedly contaminated by using SARS-CoV-2, clinicians want correct proof involving nice clinical remedies for this infection. This paper analysis the literature on all on hand records about the Treatments of COVID-19. Treatments, together with Antibodies, Vaccines, antiviral agents, convalescent plasma transfusion, corticosteroids, chloroquine and hydroxychloroquine, are mentioned in this article.
Keywords: Coronavirus Disease 2019; SARS-CoV-2; Vaccines; Treatment; Antibodies; Antiviral Agents; Crticosteroids; Chloroquine and Hydroxychloroquine
Citation: Soumitra Sahana., et al. “A Venture to Discover the Treatment of Coronavirus Disease 2019 (COVID 19): SARS-CoV-2". Acta Scientific Microbiology 3.10 (2020): 53-58.
Copyright: © 2020 Soumitra Sahana., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.